These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8465887)

  • 1. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia.
    Goldman MB; Blake L; Marks RC; Hedeker D; Luchins DJ
    Am J Psychiatry; 1993 Apr; 150(4):653-5. PubMed ID: 8465887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
    Goldman MB; Wood G; Goldman MB; Gavin M; Paul S; Zaheer S; Fayyaz G; Pilla RS
    J Clin Endocrinol Metab; 2007 Feb; 92(2):698-704. PubMed ID: 17118992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Crncević Z
    Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
    Kaneko M; Murata S; Hoshino Y; Takahagi K; Yokoyama F; Watanabe M; Kumashiro H
    Neuropsychobiology; 1990-1991; 24(1):12-6. PubMed ID: 2132636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E; Buol C; Wiedemann K; Holsboer F
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients.
    Goldman MB; Gnerlich J; Hussain N
    Neuropsychopharmacology; 2007 Jul; 32(7):1611-21. PubMed ID: 17164813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test in first-episode schizophrenia.
    Cesková E; Kaspárek T; Zourková A; Prikryl R
    Neuro Endocrinol Lett; 2006 Aug; 27(4):433-7. PubMed ID: 16892008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in newly hospitalized schizophrenic patients.
    Herz MI; Fava GA; Molnar G; Edwards L
    Am J Psychiatry; 1985 Jan; 142(1):127-9. PubMed ID: 3966575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
    Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
    Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study.
    Hawken ER; Crookall JM; Reddick D; Millson RC; Milev R; Delva N
    Schizophr Res; 2009 Feb; 107(2-3):128-33. PubMed ID: 18984069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
    Wik G; Wiesel FA; Eneroth P; Sedvall G; Aström G
    Acta Psychiatr Scand; 1986 Aug; 74(2):161-7. PubMed ID: 2877544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial dexamethasone suppression tests in male chronic schizophrenic patients.
    Myers ED
    Am J Psychiatry; 1984 Jul; 141(7):904-5. PubMed ID: 6731645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between DST nonsuppression and shortened REM latency in schizophrenia.
    Tandon R; Lewis C; Taylor SF; Shipley JE; DeQuardo JR; Jibson M; Goldman M
    Biol Psychiatry; 1996 Oct; 40(7):660-3. PubMed ID: 8886301
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test.
    Banki CM; Arató M; Rihmer Z
    Neuropsychobiology; 1984; 11(3):174-7. PubMed ID: 6472604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.